Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Gen Z workplace stereotypes were TV’s favorite punchline in 2025 - 2Germany unveils rescue plan for struggling chemical sector
- 3Scientists map of old Mars river basins for the 1st time. These could be great places to search for ancient life
- 4Advocacy groups react after Mattel introduces 1st Barbie doll with autism
- 5Home Wellness Basics: Building Your Home Exercise center
- 5 Pizza Fixings That Characterize Your Character
- Trump says Cuba is 'ready to fall' after capture of Venezuela's Maduro
- Find the Specialty of Calligraphy: Dominating the Exquisite Art of Penmanship
- Top notch DSLR Cameras for Photography Devotees
- Ukraine confirms defence and energy ministers at second attempt
- Congolese rape survivors search in vain for medicine after USAID cuts
- NAFFIC, AWARE claim first China-EU DPP for textiles
- Christmas 2025 skywatching guide: What you can see in the night sky on Dec. 25
- How will the universe end?
